Biologicals and Biosimilars: Gaps in the Pharmacovigilance System in Portugal

Biologicals and Biosimilars: Gaps in the Pharmacovigilance System in Portugal

Introduction: Biological and biosimilar medicinal products have specific characteristics that call for a closer monitoring of their safety profile. Since the current legal framework stems from both European and national regulations, some gaps in the operational field may be expected. The goal of thi...

Full description

Bibliographic Details
Main Authors: Maria da Conceição Constantino Portela, Carlos Sinogas, Fernando Albuquerque de Almeida, Ricardo Baptista-Leite, Alexandre Castro-Caldas
Format: Article
Language:English
Published: Ordem dos Médicos 2017-03-01
Series:Acta Médica Portuguesa
Subjects:
Biossimilares
Farmacovigilância
Medicamentos Biológicos
Monitorização de Fármacos
Portugal
Sistemas de Notificação de Reações Adversas a Medicamentos
Online Access:http://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/8079

Internet

http://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/8079

Similar Items